Valiant Laboratories Ltd

NSE: VALIANTLAB · BSE: 543998 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹124.25
Market cap: ₹674.8 Cr
Revenue (annual): ₹237.5 Cr
Net profit (annual): ₹-3.27 Cr
P/E (TTM): 42.2×Sector 47.4×
Promoter holding: 74.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Results Correction 2 Board Meeting Outcome 2 Board Meeting Date 2 Promoter Buying (Off-Market) 1 Merger & Restructuring 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 14:55 IST BSE

Board Meeting Date

Valiant Laboratories Board Meeting Date

Valiant Laboratories Limited has scheduled a board meeting for August 10, 2026. The board will consider and approve audited financial results for the quarter ended June 30, 2026.

Read the filing ↗

11 May 2026 15:37 IST BSE

Board Meeting Date

Valiant Laboratories Board Meeting Date

Valiant Laboratories scheduled a board meeting for May 14, 2026, to approve annual audited financial results. The trading window remains closed until May 16, 2026.

Read the filing ↗